Skip to main content
. 2018 Aug 7;9:1843. doi: 10.3389/fmicb.2018.01843

Table 2.

Antimicrobial resistance rates of C. difficile isolated in the different study sites.

Country Metronidazole Vancomycin Macrolides Moxifloxacin
Germany 0% 0% 75.9% (22/29) 65.5% (19/29)
Indonesia 0% 0% 15.2% (5/33) 24.2% (8/33)
Ghana 0% 0% 53.3% (8/15) 0%
Tanzania 0% 0% 42.9% (3/7) 0%
Total 0% 0% 45.2% (38/84) 32.1% (27/84)

Erythromycin was tested in Germany, Indonesia, and Ghana; Clarithromycin was tested in Tanzania.